Alkyne compounds of formula I ##STR00001## wherein A, B, W, X, Y, Z, R.sup.1, and R.sup.2 have the meanings given herein, which have MCH-receptor antagonistic activity and are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.